GLP-1/GIP/Glucagon Receptor Triple Agonists Unimolecular triple agonists pose the greatest potential with respect to weight loss
Combining GLP-1 medications with personalized lifestyle support can make all the difference
Fourth, we designed a peptide, CIBB, that specifically and effectively blocked the interaction between CXCL10 and IL18R1
For patients who cannot use GLP-1 or who do not respond well to it, alternatives include: Other GLP-1 receptor agonists like liraglutide or dulaglutide SGLT2 inhibitors or DPP-4 inhibitors for diabetes management Non-medication-based approaches like bariatric surgery for weight loss Your healthcare provider can guide you in choosing the best treatment based on your needs
Its broad daylight in a residential neighbourhood
Manage stress with whatever works for you: walks, breathwork, therapy, time off screens